摘要 |
<p>The present application provides novel kynurenine pathway inhibitors and pharmaceutically acceptable salts and prodrugs thereof. Also provided are methods for preparing these compounds. These compounds are useful in regulating the kynurenine pathway and the activity of indoleamine 2,3-dioxygenase and/or tryptophan 2,3-dioxygenase by administering a therapeutically effective amount of one or more of the compounds of formula (I) to a patient. By doing so, these compounds are effective in treating conditions associated with the dysregulation of the kynurenine pathway. A variety of conditions can be treated using these compounds and include diseases which are characterized by immunosuppression, abnormal cellular proliferation and/or inflammation. In one embodiment, the disease is cancer. In another embodiment, the disease is a viral infection. In a further embodiment, the disease is depression.</p> |
申请人 |
CURADEV PHARMA PVT. LTD.;BANERJEE, MONALI;MIDDYA, SANDIP;SHRIVASTAVA, RITESH;RAINA, SUSHIL;SURYA, ARJUN;YADAV, VEEJENDRA K;KAPOOR, KISHORE KAMAL |
发明人 |
BANERJEE, MONALI;MIDDYA, SANDIP;SHRIVASTAVA, RITESH;RAINA, SUSHIL;SURYA, ARJUN;YADAV, VEEJENDRA K;KAPOOR, KISHORE KAMAL |